Discover and read the best of Twitter Threads about #pplpharma
Most recents (1)
Key highlights from Piramal Pharma Q4FY23 concall
CMP - ₹82.6
Like and retweet for maximum reach!!
#pplpharma #piramalpharma #pharmastocks
CMP - ₹82.6
Like and retweet for maximum reach!!
#pplpharma #piramalpharma #pharmastocks
• CDMO business muted growth was due to macroeconomic factors resulting in delayed decision making and slowdown in biotech funding. There was also muted demand for the vitamins, minerals and generic API portfolio.
• EBITDA Margin for the year was at 12%. Adjusting for non-recurring items such as near expiry inventory provision of ₹92 Cr on account of lower demand during COVID-19 pandemic and one-off provision for receivables from a biotech customer of ₹32 Cr, the Adjusted EBITDA
